TempraMed

About

TempraMed is a company focused on providing innovative solutions for medication protection, particularly for insulin and other temperature-sensitive medications. Their flagship product, the VIVI Cap, is designed to maintain the efficacy of insulin by protecting it from extreme temperatures, ensuring safe and effective use for patients.

Verified company data

Shares outstanding

77,669,893

Fully diluted shares

111,495,927

Projects

["TempraMed’s recently launched VIVI Cap 1 is an easy-to-use reusable insulin pen cap that keeps diabetes insulin at a safe temperature 24/7 365 days a year, for years on end without need for any user intervention. The product is FDA registered and CE marked. Insulin is a protein that spoils and degrades in the wrong temperature conditions. From the point of manufacturing up until it is used, insulin needs to be kept between 36° to 46°F. During use, insulin does not have to be refrigerated but it should stay below 86°F and should not freeze. Insulin must be protected from such exposure. Injecting insulin that has broken down due to time or temperature, results in poor blood sugar control, and in time can lead to increased dosages and sometimes hospitalization for stabilization. The VIVI Cap 1 shields insulin in-use from potential temperature damage. Thus, reducing the risk of using damaged insulin and wasting money from discarded insulin that might have been compromised. Mr.Ron Nagar, TempraMed CEO and Founder, stated “After spending years recognizing the endless struggle that people with diabetes have to gain control over blood glucose levels, I noticed that those on insulin, take it for granted that insulin is always the same and at its best. But sadly, that is not the reality, so in order to protect the insulin without adding any hassle we developed this unique device and made it available for all.” VIVI Cap uses a unique patented combination of special insulation with “self-regenerating” heat absorbing material and control electronics, this enables the device to operate for years without requiring any user attention or handling. There are no power requirements, no charging and no preliminary preparations needed. For people spending their working days outdoors, there has not been an alternative hassle-free solution that can be used every day to protect insulin from spoiling."]

Leadership

Ron Nagar (Founder and CEO, Medical device serial entrepreneur and inventor. Co-Founder InsuLine Medical and Glucon.), Ilan Cohen (Executive Chairman, Serial entrepreneur and Former Director of the Israeli Prime minister's office.), Gabi Kabazo (CFO, Experienced finance and operations professional, with +25 years of experience supporting accounting, financing, and IT in complex corporate environments.), Shay Levin, CPA (CFO Israel, More than 25 years of experience in financial management, strategic planning, fundraising, cash flow oversight, investor relations, and financial reporting.), Gal Cohen (Ecommerce Director, Leading performance-driven growth, eCommerce strategy, and customer experience innovation.), Daniel Salomon (US Strategic Accounts Advisor, Ex Teva Executive 17 years at Teva. Served as Head of Sales and Marketing for Teva USA institutional business unit.), Gabriel Bitton Ph.D (VP R&D, Medical device development, Simulations, Diabetes and drug delivery expert co-founder InsuLine Medical.), Elina Nagar (Co-Founder and COO, Decades of experience in operations and systems for medical devices and Dietician.), Julia Becker (VP Capital Markets, 15 years experience in capital markets, investor relations, and business development specializing in building strategic relationships.), Brenda Zeitlin (VP Marketing, More than 25 years of experience in bringing new products to market.), Angelica Khachaturova (VP Business Development, Global Business Development, Strategy, Sales Growth and Marketing, Digital Health and Medical Devices expert.), Prof. Andreas Pfutzner M.D. (Medical Director, Managing Director and Founder of PFÜTZNER Science & Health Institute GmbH/ Germany.), Ron Nagar (Board of Directors, Medical device serial entrepreneur and inventor. Co-Founder InsuLine Medical and Glucon.), Ilan Cohen (Board of Directors, Serial entrepreneur and Former Director of the Israeli Prime minister's office.), Julia Becker (Board of Directors, 15 years experience in capital markets, investor relations, and business development specializing in building strategic relationships.), John Sinclair (Board of Directors, Senior business strategist and advisor, a CPA and CA with over 40 years of global experience with boards and audit committees, in taking companies public, and in advising and auditing public companies.)

Verified data last updated: 2026-09-25

Investor FAQ

• Latest news?→